Coumadin is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Direct_rx. The primary component is Warfarin Sodium.
Product ID | 72189-405_efded00a-22ba-1da7-e053-2995a90a58ca |
NDC | 72189-405 |
Product Type | Human Prescription Drug |
Proprietary Name | Coumadin |
Generic Name | Warfarin Sodium |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2022-12-15 |
Marketing Category | ANDA / |
Application Number | ANDA202202 |
Labeler Name | Direct_Rx |
Substance Name | WARFARIN SODIUM |
Active Ingredient Strength | 4 mg/1 |
Pharm Classes | Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2022-12-15 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
0056-0168 | COUMADIN | warfarin sodium |
0056-0169 | COUMADIN | warfarin sodium |
0056-0170 | COUMADIN | warfarin sodium |
0056-0172 | COUMADIN | warfarin sodium |
0056-0173 | COUMADIN | warfarin sodium |
0056-0174 | COUMADIN | warfarin sodium |
0056-0176 | COUMADIN | warfarin sodium |
0056-0188 | COUMADIN | warfarin sodium |
0056-0189 | COUMADIN | warfarin sodium |
43353-493 | COUMADIN | COUMADIN |
43353-492 | COUMADIN | COUMADIN |
43353-494 | COUMADIN | COUMADIN |
43353-491 | COUMADIN | COUMADIN |
50090-0028 | COUMADIN | COUMADIN |
55154-7701 | COUMADIN | COUMADIN |
55154-7706 | COUMADIN | COUMADIN |
55154-7703 | COUMADIN | COUMADIN |
55154-7704 | COUMADIN | COUMADIN |
55154-7716 | COUMADIN | COUMADIN |
55154-7702 | COUMADIN | COUMADIN |
0093-1712 | Warfarin Sodium | Warfarin Sodium |
0093-1713 | Warfarin Sodium | Warfarin Sodium |
0093-1714 | Warfarin Sodium | Warfarin Sodium |
0093-1715 | Warfarin Sodium | Warfarin Sodium |
0093-1716 | Warfarin Sodium | Warfarin Sodium |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
COUMADIN 71450506 0395328 Live/Registered |
Endo Products, Inc. 1942-01-27 |